Chemotherapy for advanced hepatocellular carcinoma Adriamycin versus quadruple chemotherapy (Q72722061)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6198058%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

title

Chemotherapy for advanced hepatocellular carcinoma. Adriamycin versus quadruple chemotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6198058%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

Chemotherapy for advanced hepatocellular carcinoma Adriamycin versus quadruple chemotherapy (English)

1 reference

10.1002/1097-0142(19840201)53:3<401::AID-CNCR2820530306>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3%3C401::AID-CNCR2820530306%3E3.0.CO;2-L

26 August 2023

1 reference

1 reference

1 reference

10.1002/1097-0142(19840201)53:3<401::AID-CNCR2820530306>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3%3C401::AID-CNCR2820530306%3E3.0.CO;2-L

26 August 2023

author name string

T. K. Choi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6198058

26 August 2023

N. W. Lee

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6198058

26 August 2023

J. Wong

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6198058

26 August 2023

language of work or name

English

0 references

publication date

1 February 1984

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6198058%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

28 October 2019

number of pages

5

1 reference

based on heuristic

inferred from page(s)

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(19840201)53:3%3C401::AID-CNCR2820530306%3E3.0.CO;2-L

1 reference

10.1002/1097-0142(19840201)53:3<401::AID-CNCR2820530306>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3%3C401::AID-CNCR2820530306%3E3.0.CO;2-L

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(19840201)53:3%3C401::AID-CNCR2820530306%3E3.0.CO;2-L

26 August 2023

1 reference

10.1002/1097-0142(19840201)53:3<401::AID-CNCR2820530306>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3%3C401::AID-CNCR2820530306%3E3.0.CO;2-L

26 August 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6198058%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

volume

53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6198058%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

page(s)

401-405

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6198058%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6198058%20AND%20SRC:MED&resulttype=core&format=json

Treatment of hepatocellular carcinoma with adriamycin.Preliminary communication

28 October 2019

cites work

1

1 reference

10.1002/1097-0142(19840201)53:3<401::AID-CNCR2820530306>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3%3C401::AID-CNCR2820530306%3E3.0.CO;2-L

Further experience in treating patients with hepatocellular carcinoma in Uganda

26 August 2023

2

1 reference

10.1002/1097-0142(19840201)53:3<401::AID-CNCR2820530306>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3%3C401::AID-CNCR2820530306%3E3.0.CO;2-L

Induction of remission in hepatocellular carcinoma with doxorubicin

26 August 2023

3

1 reference

10.1002/1097-0142(19840201)53:3<401::AID-CNCR2820530306>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3%3C401::AID-CNCR2820530306%3E3.0.CO;2-L

A phase II study of adriamycin (NSC 123127) in patients with hepatocellular carcinoma from Zambia and the United States

26 August 2023

4

1 reference

10.1002/1097-0142(19840201)53:3<401::AID-CNCR2820530306>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3%3C401::AID-CNCR2820530306%3E3.0.CO;2-L

Chemotherapy studies in primary liver cancer. A prospective randomized clinical trial

26 August 2023

5

1 reference

10.1002/1097-0142(19840201)53:3<401::AID-CNCR2820530306>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3%3C401::AID-CNCR2820530306%3E3.0.CO;2-L

Doxorubicin for liver cancer

26 August 2023

6

1 reference

10.1002/1097-0142(19840201)53:3<401::AID-CNCR2820530306>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3%3C401::AID-CNCR2820530306%3E3.0.CO;2-L

Quadruple chemotherapy versus radiotherapy in treatment of primary hepatocellular carcinoma

26 August 2023

7

1 reference

10.1002/1097-0142(19840201)53:3<401::AID-CNCR2820530306>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3%3C401::AID-CNCR2820530306%3E3.0.CO;2-L

Intraarterial hepatic infusion and intravenous adriamycin for treatment of hepatocellular carcinoma.A clinical and pharmacology report

26 August 2023

10

1 reference

10.1002/1097-0142(19840201)53:3<401::AID-CNCR2820530306>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3%3C401::AID-CNCR2820530306%3E3.0.CO;2-L

26 August 2023

Cancer Treatment Reports

11

61

1595

Baker

1977

1 reference

10.1002/1097-0142(19840201)53:3<401::AID-CNCR2820530306>3.0.CO;2-L

https://api.crossref.org/works/10.1002/1097-0142(19840201)53:3%3C401::AID-CNCR2820530306%3E3.0.CO;2-L

26 August 2023

Identifiers

10.1002/1097-0142(19840201)53:3<401::AID-CNCR2820530306>3.0.CO;2-L

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6198058%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference